Stockreport

Acasti, Matinas rise on Amarin heart drug news [Seeking Alpha]

Acasti Pharma, Inc. - Class A  (ACST) 
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: acastipharma.com/investors
PDF Acasti, Matinas rise on Amarin heart drug news Acasti Pharma (NASDAQ: ACST MTNB FDA panel win ACST is up 12.3% up 12.2% The two are similar-sized peers to Amarin in the [Read more]